Life Stem Genetics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIFS research report →
Price Chart
About the company
Life Stem Genetics Inc. , an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services.
- CEO
- Gloria Simov
- IPO
- 2013
- HQ
- East Stroudsburg, PA, US
Get TickerSpark's AI analysis on LIFS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.58K
- P/E
- -2.53
- PEG
- -0.03
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.47
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-9,700
- Net Income
- $-9,700+8.2%
- EPS
- $0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.00
- RSI (14)
- 9
- Avg Volume
- 327
No earnings-call transcripts are available for LIFS yet.
- Free Float
- 41.3%
- Shares Outstanding
- 45.84M
- Float Shares
- 18.92M
Our LIFS coverage
Recent articles, reports, and earnings notes.
No research on LIFS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LIFS report →